GSK said the mixed Phase 3 results for camlipixant mean this pill “is unlikely to transform patient care” in recurrent chronic cough. GSK is stopping
The opportunity ahead is to treat physician well-being as a core strategic priority, measured with the same rigor and acted upon with the same urgency
New 3D printed technology makes lower extremity surgeons architects of restoration, not adaptation. The post Why Settle for Acceptable Versus Optimal Outcomes? appeared first on
The House Ways and Means Committee unanimously advanced a bill to reform Medicare Advantage prior authorization requirements. The post Healthcare Groups Praise Unanimous Committee Approval
CMS’ proposed 2027 Physician Fee Schedule would bar Medicare payment for remote monitoring services delivered by third-party vendors, following OIG reports that flagged widespread fraud
Eli Lilly’s AtaiBeckley acquisition marks a dozen M&A deals for the pharma company so far this year. AtaiBeckley’s lead program is an intranasally administered psychedelic
HealthGility provides healthcare organizations with a solution for patient protected health information disclosure and confidentiality that reduces workloads and ensures the safe and secure sharing of sensitive data between different providers.
